ContextVision AB (publ) (0L8Z) Q2 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Welcome to Context Vision and welcome to the presentation of our second quarter results. Today with Richard, our CFO, myself, Gerald, we have an agenda with three agenda items, a business update, a deep dive into the financial development and a brief summary and outlook. Without further ado, let's look into the business update and the second quarter 2025. We continue to expand our partnership network to advance into quantitative ultrasound and in the second quarter we have signed up University of Waterloo, InFace Solutions and Amra Medical. We have attended a conference CMEF in Shanghai in April. We have signed up a new customer and a new platform also in Asia and that was within specialty ultrasound. And I'm very excited that we have released in the second quarter a major revamped upgrade as well as a completion of an entirely new software platform with a new architecture that will be the foundation for an entire new series of products that are going to be clinically focused. Now looking at the financials, we saw a decline in revenues to 28.6 million SIC and that's a 10% decline compared to previous year. EBITDA amounted to 5.1 million SIC and that is adjusted for investments into data quality and corresponds to a 7.8% EBITDA margin. Operating cash flow was 1.5 million SEK. So in total for the first half year, we can report revenue amounting to 54.9 million SEK and an EBITDA of 7.2 million SEK. So again, most impact due to external factors while factors in our control like when a loss of new platforms remain stable. But Richard is going to dive deeper into the circumstances around the financials in a minute. But let's spend two more slides on the development of the business. And in the long run, we see that we're trending sideways looking at the 12-month rolling rev...